Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell Pouch for Therapeutic Islet Transplantation

Trial Profile

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell Pouch for Therapeutic Islet Transplantation

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 12 Apr 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Islet cell replacement therapy (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; First in man; Proof of concept
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 22 Dec 2016 According to a Sernova media release, this study is sponsored by JDRF.
    • 22 Dec 2016 According to a Sernova media release, update on the company's corporate and business strategy will be presented at the 9th annual Biotech Showcase Conference in San Francisco.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top